Viewing Study NCT04564066


Ignite Creation Date: 2025-12-24 @ 4:26 PM
Ignite Modification Date: 2025-12-25 @ 4:41 PM
Study NCT ID: NCT04564066
Status: COMPLETED
Last Update Posted: 2021-04-05
First Post: 2020-09-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Study to Compare the Safety and Effect of Efgartigimod as an Intravenous Infusion With the Effect of Efgartigimod as a Subcutaneous Injection in Healthy Volunteers
Sponsor: argenx
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module